Cargando…
Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair
Prostate cancer (PCa) is one of the most prevalent male cancers in western world. Radiation therapy (RT) is commonly used to treat PCa patients. However, a certain proportion of patients develop radioresistant PCa cells, which results in metastatic disease. Statins, which inhibit 3-hydroxy-3-methyl...
Autores principales: | Chen, Yu-An, Shih, Hua-Wei, Lin, Yi-Chun, Hsu, Hui-Ying, Wu, Tsu-Fang, Tsai, Chen-Han, Wu, Chia-Lin, Wu, Hui-Yu, Hsieh, Jer-Tsong, Tang, Chih-Hsin, Lai, Chih-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008406/ https://www.ncbi.nlm.nih.gov/pubmed/29950990 http://dx.doi.org/10.3389/fphar.2018.00600 |
Ejemplares similares
-
Sensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems
por: Chen, Yu-An, et al.
Publicado: (2017) -
Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia
por: Chen, Yu-An, et al.
Publicado: (2018) -
Bora Downregulation Results in Radioresistance by Promoting Repair of Double Strand Breaks
por: Cairns, Junmei, et al.
Publicado: (2015) -
Mitochondrial protection by simvastatin against angiotensin II‐mediated heart failure
por: Hsieh, Chong‐Chao, et al.
Publicado: (2019) -
Simvastatin Is Effective in Killing the Radioresistant Breast Carcinoma Cells
por: Aschenbrenner, Bertram, et al.
Publicado: (2021)